Abdul J. Tajik
Mayo Clinic
AnatomyInternal medicineRadiologySurgeryCardiologyHemodynamicsCardiac catheterizationMitral valveHeart failureVentricleTricuspid valveStenosisHeart diseaseRegurgitation (circulation)Doppler echocardiographyAortic valveMitral regurgitationIn patientTwo dimensional echocardiographyDiastoleMedicine
Publications 172
Contrast echocardiography aids in endocardial definition in stress testing, and we evaluated its use in apical hypertrophic cardiomyopathy (AHCM). AHCM is characterized by severe apical hypertrophy, and complications include apical pouch development that is associated with high rate of
Abstract Previous studies on small numbers of patients have indicated a high incidence of increased right ventricular dimension and abnormal ventricular septal motion in patients with atrial septal...
#1Timothy E. Paterick (Houston Methodist Hospital)H-Index: 2
#1Timothy E. PaterickH-Index: 15
Last. Abdul J. TajikH-Index: 62
view all 6 authors...
: Physicians participate in the screening, routine medical supervision, and disqualification of student-athletes. In doing so, they should understand that eligibility/disqualification decisions inevitably have associated liability issues. It is the responsibility of physicians to take the lead role in the student-athlete medical assessment process to allow for optimum safety in sports programmes. The first duty of the physician is to protect the health and well-being of the student-athlete. Howe...
1 CitationsSource
#2Heidi M. Connolly (Mayo Clinic)H-Index: 75
Last. Abdul J. Tajik (Mayo Clinic)H-Index: 62
view all 7 authors...
109 CitationsSource
#1Rick A. Nishimura (Mayo Clinic)H-Index: 128
#2Steve R. Ommen (Mayo Clinic)H-Index: 78
Last. Abdul J. Tajik (Mayo Clinic)H-Index: 62
view all 3 authors...
Affecting approximately one in every 500 people, hypertrophic cardiomyopathy is a unique disease in which there is an abnormal increase in the thickness of the heart muscle. Although the cause of hypertrophic cardiomyopathy was unknown in the past, it is now recognized that people with hypertrophic cardiomyopathy have a gene mutation that causes this abnormality. Most people with hypertrophic cardiomyopathy are relatively asymptomatic and able to maintain a normal lifestyle, but there are some w...
16 CitationsSource
#1Saeed Al-Ahmari (Mayo Clinic)H-Index: 1
#2Krishnaswamy Chandrasekaran (Mayo Clinic)H-Index: 35
Last. Abdul J. Tajik (Mayo Clinic)H-Index: 62
view all 9 authors...
Abstract Isolated partial anomalous pulmonary venous connection is frequently missed even when patients present with mild right ventricular enlargement. We describe the value of imaging from suprasternal window with color flow and ultrasound contrast echocardiography in aiding the diagnosis.
19 CitationsSource
#1Nalini M. Rajamannan (NU: Northwestern University)H-Index: 31
#2Malayannan Subramaniam (Mayo Clinic)H-Index: 48
Last. Thomas C. Spelsberg (NU: Northwestern University)H-Index: 85
view all 11 authors...
Background— Calcific aortic stenosis is the third most common cardiovascular disease in the United States. We hypothesized that the mechanism for aortic valve calcification is similar to skeletal bone formation and that this process is mediated by an osteoblast-like phenotype. Methods and Results— To test this hypothesis, we examined calcified human aortic valves replaced at surgery (n=22) and normal human valves (n=20) removed at time of cardiac transplantation. Contact microradiography and mic...
610 CitationsSource
#1Sherif F. Nagueh (BCM: Baylor College of Medicine)H-Index: 84
#2Steve R. Ommen (Mayo Clinic)H-Index: 78
Last. William H. Spencer (BCM: Baylor College of Medicine)H-Index: 23
view all 10 authors...
OBJECTIVES This study was designed to compare the hemodynamic efficacy of nonsurgical septal reduction therapy (NSRT) by intracoronary ethanol with standard therapy (surgical myectomy) for the treatment of hypertrophic obstructive cardiomyopathy (HOCM). BACKGROUND Nonsurgical septal reduction therapy has gained interest as a new treatment modality for patients with drug-refractory symptoms of HOCM; however, its benefits in comparison to surgery are unknown. METHODS Forty-one consecutive NSRT pat...
204 CitationsSource
#1Helen L. Thomson (Mayo Clinic)H-Index: 6
Last. Abdul J. Tajik (Mayo Clinic)H-Index: 62
view all 3 authors...
: Patients with severe mitral regurgitation (MR) who are managed conservatively sustain excess mortality and morbidity. With improved mortality and morbidity rates being achieved with surgical management, cardiologists and cardiac surgeons are becoming more aggressive in treating patients with severe MR with surgery. Recent data indicate that even in the absence of symptoms or left ventricular dysfunction, surgery should be offered as a treatment for MR, provided that the regurgitation is severe...
10 CitationsSource